Ocular Cicatricial Pemphigoid
What this disease is
Ocular cicatricial pemphigoid is a rare disease of the eye surface. It is the eye form of a wider disease called mucous membrane pemphigoid. That wider disease can also affect the mouth, nose, throat, and other moist linings. In the eye, the body's own immune cells attack the lining under the conjunctiva. The conjunctiva is the clear film over the white of the eye and inner lids.
The attack causes slow waves of swelling. Each wave leaves a small scar. Over months and years, the scars build up. The lid spaces grow shorter. The lid lining can stick to the eyeball. Without care, scarring spreads to the cornea. Vision can drop a lot, and some patients go blind.
Many people are found late. Early signs look like dry eye or pink eye. By the time scars are easy to see, harm may be done. Red eyes that do not heal with normal drops should be checked. A cornea or eye-immune doctor often helps lead care once this disease is in mind.
Causes and risk factors
The disease comes from autoantibodies. These are immune proteins that hit the patient's own tissue by mistake. In this disease, they bind to the basement membrane zone. That is the thin layer that holds the surface to the deeper tissue. Targets include a protein called BP180 and parts of integrin. When they bind, they set off long swelling and scarring.
This disease is not common. It mostly shows up in older adults. Most cases start in the sixties or later. Women get it a bit more often than men. Reported case rates change by region. There is no clear inherited pattern. Still, autoimmune disease can run in some families.
The same disease can affect more than the eye. Patients may also have:
- Mouth blisters or sore gums that bleed with brushing
- Nose crusts, nosebleeds, or scars inside the nose
- Throat or voice-box scars that cause hoarse voice or trouble with food
- Skin blisters, often on the head, neck, or upper trunk
- Sores or scars in the genital area
Eye surgery on a flared eye can speed scarring. Doctors call this the cicatricial cascade. Some glaucoma drops and other long-term drops have been linked to a like pattern. That pattern is called pseudopemphigoid. Bring all current eye drops to each visit so the team can check them.
Symptoms and signs
Early signs are vague. Patients feel grit, redness, tearing, and light glare. Eyes feel tired and sore. Vision is often still normal. That is one reason care is delayed. Both eyes are usually hit. One side may be worse.
At the slit lamp, the doctor looks for clues that point to scarring. These include:
- Symblepharon, small bands of scar that bridge the inner lid to the eyeball
- Forniceal foreshortening, the shrinking of the lid pocket
- Trichiasis, lashes that turn inward and rub the cornea
- Entropion, a lid that rolls inward
- Keratinization, a dry, skin-like change on the wet surface
- Corneal scars, new vessels, or surface breaks
Late in the course, the lid can fuse to the eyeball in spots. Doctors call that ankyloblepharon. The cornea may turn cloudy. Vessels grow on it. Tear flow drops because the glands are scarred. Vision may fall to counting fingers or worse.
Patients should bring up other body changes. These include mouth sores, gum bleeding, nose crusts, hoarse voice, hard swallows, or genital sores. These extra clues help confirm the disease. They also shape the care plan.
How clinicians diagnose it
The diagnosis is made with a small tissue sample called a biopsy. The lab runs a test called direct immunofluorescence on it. The lab looks for a thin line of immune proteins along the basement membrane zone. That line can include IgG, IgA, or C3. This linear pattern is the hallmark of pemphigoid. It helps tell this disease from other red-eye causes.
The deposits can be patchy. So a single biopsy can miss the disease. A second biopsy from a new spot can help. Sampling near visible scars also helps. The team uses clinical judgment when biopsy is clean but the picture still fits.
Blood tests can pick up some autoantibodies. They support but do not replace biopsy. Some patients with the full disease have clean blood tests. Slit-lamp photos help track progress over time. Tear tests and cultures may be added if dry eye or infection is in question.
Once the diagnosis is set, doctors use Foster staging. This shows how far the disease has gone. The four stages are:
- Stage 1, long pink eye with thin scar visible only on close exam
- Stage 2, lid pocket shrinkage that can be measured at the slit lamp
- Stage 3, scar bands that link the lid to the eyeball
- Stage 4, lid fused to the eyeball with end-stage surface failure
The stage helps guide how strong treatment must be. It also guides which doctors join the team.
Treatment to control the immune system
Eye drops alone cannot stop this disease. The disease is driven by the body's immune system. So the medicine must work through the whole body. The goal is to calm the swelling enough to stop new scars. Then the team holds that calm state for years. Care is often shared with an eye-immune doctor or a rheumatologist. These doctors know autoimmune blistering disease well.
The choice depends on how bad the disease is, how fast it moves, and the patient's health. Common options include:
- Dapsone, often used for mild or slow disease
- Methotrexate, mycophenolate mofetil, and azathioprine for moderate disease
- Cyclophosphamide, a stronger drug used for fast or hard cases
- Rituximab, a targeted antibody drug for tough cases
- Intravenous immunoglobulin, used in some hard cases
While the body drugs do the main work, the eye surface still needs care. Preservative-free artificial tears help dry eyes. Punctal plugs can hold more tears on the eye. Treatment of trichiasis with epilation, electrolysis, or lid surgery keeps lashes off the cornea. None of this surface care can replace body therapy.
Long-term immune drugs need blood tests. The labs check the liver, kidneys, blood counts, and immune work. Patients are also checked for infections that can hit immune-low patients harder. The plan is changed when labs shift or new symptoms appear. Any new drug from another doctor should be checked against the plan.
Surgery and the cicatricial cascade
Surgery on a flared eye can make the disease worse. The shock of surgery can flare swelling. That flare can cause a new wave of scarring. The new wave can be worse than the first problem. Doctors call this the cicatricial cascade. Cataract surgery, glaucoma surgery, and even lash work can set it off if the eye is not first calm.
If a patient with this disease needs cataract or other surgery, timing is key. The team waits for the eye to be calm for several months on body therapy. Immune drugs may be raised for a short time around surgery. The team adjusts anesthesia, drops, and cut size to keep tissue stress low.
When the eye surface has failed, special surgeries may help:
- Mucous membrane grafts, often from the inside of the lip, to rebuild scarred lid pockets
- Limbal stem cell transplant in chosen patients
- Keratoprosthesis, a man-made cornea, for end-stage scars when a normal transplant would fail
These steps are demanding. They need long-term immune therapy and close follow-up to hold the result.
Recent developments and what is changing
Doctors now have a lower bar for biopsy in long-running red eyes. Earlier biopsy means earlier diagnosis. Earlier care can start before big scars form. This shift has likely helped long-term results. Still, disease found at stage 3 or 4 holds a real risk to vision.
Rituximab cuts the immune cells that make autoantibodies. It is now a key choice for patients who do not respond to older drugs. Other biologic drugs from related diseases are being studied. The trend is toward narrow immune therapy with fewer broad side effects.
Modern care often uses a team. The team can include a cornea doctor, eye-immune doctor, skin doctor, mouth doctor, and rheumatologist. Patients on a coordinated team tend to have better disease control. They also have fewer drug-related problems than patients with a solo doctor.
Prognosis and long-term outlook
With early care and the right body therapy, many patients reach long quiet periods. Vision can stay stable. Full remission off all drugs is not common. Most patients still need some level of care over time. Earlier diagnosis tends to mean a better long-term outlook.
One common reason is tapering drugs too fast. The autoimmune drive that caused the first scars is still there. So pulling immune drugs often allows swelling to come back. Drug changes are made slowly. They follow a long quiet period.
Even with control, dry eye, light glare, and lower contrast can hit daily life. Low-vision rehab can help. Scleral contact lenses can shield the surface and sharpen vision. Lighting changes at home and work also help. Mental-health support is fair to consider for any chronic vision-threat illness.
When to see a doctor
Anyone with red, sore eyes that do not heal in a few weeks should be checked. The need is more urgent with mouth sores, nose crusts, hoarse voice, or new skin blisters at the same time. That mix raises concern for mucous membrane pemphigoid. Sudden vision loss, sharp pain, or a white spot on the cornea calls for same-day care.
This disease is rare. Many general eye doctors see only a few cases over a career. Once it is on the table, sending the patient to a cornea or eye-immune doctor often helps. These doctors know autoimmune surface disease well. They can speed the diagnosis and shape clear care plans.
A complete list of all eye drops helps a lot. So does a list of pills, vitamins, and creams from other doctors. Past slit-lamp photos and biopsy reports are also useful. Bringing a written list of symptoms and how long they have lasted saves time. Patients who use ride-share or family for the trip plan well, since pupil drops can blur vision after the visit.
Common questions about living with ocular cicatricial pemphigoid
No. The disease comes from your own immune system, not a germ. It cannot pass to other people through close contact, towels, or shared cups. Family members do not need tests unless they show signs of their own. The mix-up with pink eye is common but not correct.
Most patients do need long-term care. The drug and dose often change over time. Some patients reach a low maintenance dose. Drug-free remission is less common. Stopping drugs on your own often causes a flare, so any change should go through the prescriber.
Maybe, but timing is key. Surgery on a flared eye can worsen scars. The team first calms the swelling with body therapy. Then they wait for a quiet period of several months. They may add extra anti-swelling cover around the surgery date. The call is best made by a cornea doctor who knows this disease.
Yes. Some drop preservatives can stress already swollen tissue. They have been linked to a like pattern called pseudopemphigoid. Patients with this disease are usually placed on preservative-free artificial tears. The team also reviews all drops at each visit, including over-the-counter ones.
A pseudopemphigoid pattern has been linked to long-term use of some glaucoma drops and a few body drugs. If you use long-term drops for any chronic eye issue, share them all with the team. Sometimes a switch to a preservative-free form, or a new drug, becomes part of the plan.
Helpful questions include how soon you may feel better and what side effects to watch for. Ask what blood tests you will need and how often. Ask about infection risk and any vaccines you may need. It is fair to ask if your prescriber will share notes with your primary doctor and your other doctors.
Most patients with stable disease can work, drive, and travel. Patients on immune drugs should plan trips with the care team, since some places have germs that hit immune-low people harder. Dry, dusty, or air-cooled work spaces may need humidifiers, more lubricant drops, or guard glasses.
For patients found early and treated steadily, vision often stays stable for years. For those with late-stage scars at the start, the goal shifts. The plan moves to keeping what is left, with surface care, scleral lenses, and low-vision tools. Honest, regular talks with the care team show each patient's true outlook.
Schedule a cornea evaluation with our team
Long-running red eyes that have not healed with normal drops deserve a careful look. Our office sees patients with possible ocular cicatricial pemphigoid, plans biopsy, and works with eye-immune teams on body therapy. We also support long-term surface care for known disease. Call our team to book an exam and start a clear, shared plan to protect your vision.